In a head-to-head trial in adults with obesity or overweight without diabetes, tirzepatide, the active ingredient in Mounjaro and Zepbound led to greater average weight loss than semaglutide over 72 weeks.However, there are various factors to consider when determining which medication is the best fit for an individual's unique needs including cost and insurance coverage, overall health, side effects, and how well the medication aligns with one's lifestyle and goals
They are better understood as part of a structured treatment process
These aren't minor benefitsthey're life-changing improvements that address the root causes of PCOS, not just its surface symptoms
Instead, they will start the medication from the starting dose and titrate it gradually
The likelihood of developing cataracts increases with age
Over the forecast period from 2025 to 2034